| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 796.20M | — |
| Operating expense | — | — |
| Net income | 57.66M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, AMRX returned +86.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +42.1% |
| 1 year | +86.8% |
| 5 years | +217.6% |
| All-time high | $23.10 (Aug 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in AMRX would be worth today ›No. Amneal Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Amneal Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol AMRX.
Amneal Pharmaceuticals, Inc. is part of the Healthcare sector.
Amneal Pharmaceuticals, Inc. has a market cap of 6.24B USD, based on the latest quote.
Amneal Pharmaceuticals, Inc. is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
